Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other financing activities: 2010-2019

Historic Other financing activities for Sunshine Biopharma (SBFM) over the last 5 years, with Dec 2019 value amounting to $7,590.

  • Sunshine Biopharma's Other financing activities fell 98.92% to $7,590 in Q4 2019 from the same period last year, while for Dec 2019 it was $603,566, marking a year-over-year decrease of 10.73%. This contributed to the annual value of $676,100 for FY2018, which is 58.19% up from last year.
  • As of Q4 2019, Sunshine Biopharma's Other financing activities stood at $7,590, which was up 200.00% from -$7,590 recorded in Q2 2019.
  • Sunshine Biopharma's 5-year Other financing activities high stood at $705,568 for Q4 2018, and its period low was -$411,566 during Q2 2018.
  • Its 3-year average for Other financing activities is $110,350, with a median of $10,995 in 2017.
  • The largest annual percentage gain for Sunshine Biopharma's Other financing activities in the last 5 years was 3,261.81% (2018), contrasted with its biggest fall of 743.07% (2018).
  • Sunshine Biopharma's Other financing activities (Quarterly) stood at $282,800 in 2016, then slumped by 120.05% to -$56,700 in 2017, then skyrocketed by 1,344.39% to $705,568 in 2018, then crashed by 98.92% to $7,590 in 2019.
  • Its last three reported values are $7,590 in Q4 2019, -$7,590 for Q2 2019, and $705,568 during Q4 2018.